What is the price band of Sudeep Pharma Ltd. IPO?

The price band of Sudeep Pharma Ltd. IPO is ₹563-593 per share, with a face value of ₹10 per share.

What is the lot size of Sudeep Pharma Ltd. IPO?

The minimum lot size for Sudeep Pharma Ltd. IPO is 25 shares.

When does Sudeep Pharma Ltd. IPO open and close?

Sudeep Pharma Ltd. IPO opens on Nov 21, 2025 and closes on Nov 25, 2025.

When will Sudeep Pharma Ltd. IPO allotment be finalized?

The allotment for Sudeep Pharma Ltd. IPO will be finalized on Nov 26, 2025.

What is the listing date of Sudeep Pharma Ltd. IPO?

Sudeep Pharma Ltd. will list on BSE, NSE on Nov 28, 2025.

What is the current GMP (Grey Market Premium) of Sudeep Pharma Ltd. IPO?

As of 6 August 2026, the GMP for Sudeep Pharma Ltd. IPO is ₹121 (20.4%). (Note: GMP is unofficial and changes daily.)

What is the total issue size of Sudeep Pharma Ltd. IPO?

The total issue size of Sudeep Pharma Ltd. IPO is ₹895.00 Cr.

What is the minimum and maximum investment for retail investors in Sudeep Pharma Ltd. IPO?

Retail investors can apply for a minimum of 1 lot (25 shares).

What are the strengths of Sudeep Pharma Ltd. IPO?

The key strengths of Sudeep Pharma Ltd. include strong business fundamentals, experienced management, and growing market presence.

What are the risks/weaknesses of Sudeep Pharma Ltd. IPO?

The main risk factors for Sudeep Pharma Ltd. include market competition and industry regulatory changes.

Should I apply for Sudeep Pharma Ltd. IPO?

Sudeep Pharma Ltd. IPO is currently closed. Its GMP stands at ₹121 (20.4%). Investors should consult a registered financial advisor before deciding.

Sudeep Pharma Ltd. (MAINBOARD)

MainboardClosed

Min. Investment

₹14,825

/ 25 Shares

Check Allotment Status

Issue Price

563-593

Subscription

Issue Size

895.00

Lot Size

Open

Nov 21, 2025

Nov 25, 2025

Allotment

Nov 26, 2025

Listing

Nov 28, 2025

Grey Market Premium

Estimated listing gains (Live)

+121 (20.4%)Per Share

EST. GAINS

Updated real-time from market sources

Frequently Asked Questions (Sudeep Pharma Ltd.)

Founder | India IPO Updates

DIPAK DANGODARA

I am the founder of India IPO Updates, a platform dedicated to tracking the Indian IPO market since 2024. With a background in digital research and data analysis, I built this platform to simplify IPO tracking covering issue details, live Grey Market Premium (GMP), subscription status, and allotment updates sourced from public exchange data and verified market sources.

I am not an SEBI-registered investment advisor. All GMP and market data shared here is for informational purposes only and should not be considered investment advice. Investors are advised to consult a registered financial advisor before making investment decisions.

Your Brand Here

Your Brand Here

Sudeep Pharma Ltd. (MAINBOARD)

Grey Market Premium

Frequently Asked Questions (Sudeep Pharma Ltd.)

DIPAK DANGODARA

Help others stay informed